Patent application number | Description | Published |
20140373426 | FLASHING FISH LURE - A flashing fish lure includes a bore to receive a glow stick. At least one water wheel on or in the body rotates as the body is pulled through water. Each water wheel includes at least one aperture, such that as the water wheel rotates, light is intermittently communicated from the glow stick, through the aperture, and out or both of the opposing side surfaces to appear as a flashing light. The glow stick may use a chemiluminescent or phosphorescent material. An end of the glow stick may remain exposed following insertion, and a decorative skirt or other fish-attracting material may be attached to the exposed end of the glow stick. Two water wheels may be supported on respective opposing sides of the body, each with a plurality of water-catching vanes extending radially outwardly from a central axis about which each wheel rotates. | 12-25-2014 |
20150063892 | DEVICES AND METHODS FOR APPLYING BODY LOTIONS SUCH AS SUNSCREENS - Hand-held articles are disclosed for applying lotion to a user, including a user's back or other hard-to-reach places. A housing contains a lotion to be dispensed, and a member, integral to the housing, transfers the lotion to a user's body. The member may be a roller or a pre-moistened, elongated sheet, web or strip, with the housing containing a roll of pre-moistened material. The housing may further include a manually operated lever that allows a length of the strip to be pulled from the roll in the housing. The housing may additionally include a cap with a cutting edge to sever the strip at a desired length. The strip of material may be pre-moistened with a tanning lotion; self-tanning lotions; sun block; moisturizing cream, or insect repellant. The strip of material may be made of a non-woven synthetic fibrous material, with a width in the range of 1 to 3 inches. | 03-05-2015 |
Patent application number | Description | Published |
20110022089 | SYSTEMS AND METHODS FOR FACET JOINT TREATMENT - A system for treating a facet joint of a patient including superior and inferior resurfacing devices. The superior device includes a resurfacing body configured to conform to a shape of a superior facet articular face, and the inferior device includes a resurfacing body configured to conform to a shape of an inferior facet articular face. Each resurfacing body exhibits sufficient flexibility to transition from a relatively flat state to an inserted state in which the resurfacing body substantially matches any multi-planar concavities of the corresponding facet articular face in the presence of compressive forces. With this construction, the system is capable of establishing a new sliding interface within the facet joint, and can be inserted on a minimally-invasive basis. The resurfacing bodies can be formed of PEEK, and can include teeth that engage the corresponding facet articular face. | 01-27-2011 |
20110082548 | LOW FRICTION RESURFACING IMPLANT - A low friction resurfacing implant system including a first implant component and a second implant component. The first implant component has a first bearing surface. The second implant component has a second bearing surface. The first implant component and the second implant component are each fabricated from a durable material that possesses a low coefficient of friction. | 04-07-2011 |
20110166575 | SACROILIAC FUSION SYSTEM - An undercutting system for preparing a region between ilium and sacrum for sacroiliac fusion. The undercutting system includes an insertion apparatus and a cutting assembly. The cutting assembly is operably attached to the insertion apparatus. The cutting assembly is movable with respect to the insertion apparatus between a retracted configuration and an extended configuration. | 07-07-2011 |
20120323285 | BONE SCREW - A bone screw including a main body portion having a proximal end and a distal end. An external threaded surface and an internal threaded surface are formed on the main body portion. The external threaded surface intersects the internal threaded surface proximate a lower surface of the external threaded surface and a lower surface of the internal threaded surface. A plurality of bone growth apertures is defined on the surface of the main body portion where the external threaded surface and the internal threaded surface are not located. The bone growth apertures comprise between about 10 percent and about 60 percent of the surface of the main body portion. | 12-20-2012 |
20130030456 | SACROILIAC FUSION SYSTEM - An undercutting system for preparing a region between an ilium and a sacrum for sacroiliac fusion. The undercutting system includes a probe assembly and a cutting assembly. The probe assembly is operably mounted to the insertion apparatus. The probe assembly is moveable with respect to the insertion apparatus between a retracted configuration and an extended configuration. In the extended configuration at least a portion of the probe assembly extends laterally from the insertion apparatus. The cutting assembly is operably mounted with respect to the probe assembly and the insertion apparatus. The cutting assembly is movable with respect to the insertion apparatus between a retracted configuration and an extended configuration. In the extended configuration at least a portion of the cutting assembly extends laterally from the insertion apparatus. | 01-31-2013 |
20130158666 | FACET FUSION SYSTEM - A facet fusion system including a first drill guide, a second drill guide and a facet fusion implant. The first drill guide has a first aperture formed therein. The second drill guide has a second aperture formed therein. A position of the first aperture on the first drill guide is offset from a position of the second aperture on the second drill guide. The facet fusion implant has at least one gripping region and at least one bone growth region. The at least one bone growth region has a diameter that is larger than a diameter of the first aperture and the second aperture. | 06-20-2013 |
20130190879 | METHODS FOR FACET JOINT TREATMENT - A method of treating a facet joint of a patient. The facet joint includes a superior facet having superior articular face and an inferior facet having an inferior articular face. A distal end of an implant delivery cannula is extended between the superior and inferior articular faces. The implant delivery cannula has a channel extending therethrough. An implant is moved through the channel until the implant is between the superior and inferior articular faces while at least a portion of the implant is within the channel. The implant includes a first surface and a second surface. The implant delivery cannula is moved away from the superior and inferior articular faces so that the first surface is adjacent the superior articular face and the second surface is adjacent the inferior articular face. | 07-25-2013 |
20130197590 | SACROILIAC FUSION SYSTEM - An undercutting system for preparing a region between an ilium and a sacrum for sacroiliac fusion. The undercutting system includes an insertion apparatus, a probe assembly and a cutting assembly. The probe assembly is operably mounted to the insertion apparatus. The probe assembly is moveable with respect to the insertion apparatus between a retracted configuration and an extended configuration. In the extended configuration at least a portion of the probe assembly extends from the insertion apparatus. The cutting assembly is operably mounted with respect to the probe assembly and the insertion apparatus. The cutting assembly is movable with respect to the insertion apparatus between a retracted configuration and an extended configuration. In the extended configuration at least a portion of the cutting assembly extends from the insertion apparatus. | 08-01-2013 |
20130197645 | SYSTEMS AND METHODS FOR FACET JOINT TREATMENT - A facet implant system for implanting between a superior facet and an inferior facet. The facet implant system includes a first facet implant component and a second facet implant component. The first facet implant component has a first articulating surface and a first engagement surface located opposite the first articulating surface. The first facet implant component has a leading edge and a trailing edge. The first facet implant component has teeth that extend from the first engagement surface. The teeth are arranged in a plurality of rows and wherein teeth in adjacent rows are offset from each other. The second facet implant component has a second articulating surface and a second engagement surface located opposite the second articulating surface. The second facet implant component has teeth that extend from the second engagement surface. | 08-01-2013 |
20130226181 | SACROILIAC FUSION SYSTEM - An undercutting system for preparing a region between ilium and sacrum for sacroiliac fusion. The undercutting system includes an insertion apparatus and a cutting assembly. The insertion apparatus has an elongate shaft and a rotatable handle. The cutting assembly is operably attached to the insertion apparatus. Rotation of the handle with respect to the shaft causes the cutting assembly to move with respect to the shaft between a retracted configuration and an extended configuration. When in the extended configuration, at least a portion of the cutting assembly extends laterally from the shaft. | 08-29-2013 |
20140088596 | METHOD OF REPAIRING SACROILIAC FUSION - A method of repairing a prior sacroiliac fusion that was not effective at stabilizing a sacroiliac joint. The prior sacroiliac fusion used a first fastening device that extended between an ilium and a sacrum. At least one aperture is formed that at least partially extends through at least one of an ilium and a sacrum. An undercutting system is inserted at least partially into the aperture and is used to cut tissue between the ilium and the sacrum. A second fastening device is inserted into the first aperture to retain the ilium in a stationary position with respect to the sacrum. | 03-27-2014 |
20140135938 | LOW FRICTION RESURFACING IMPLANT - A low friction resurfacing implant system including a first implant component having a first bearing surface and a first engagement surface. The first engagement surface is located opposite the first bearing surface. The first implant component has a leading edge and a trailing edge. The first implant component includes teeth that extend from the first engagement surface. The teeth are arranged in a plurality of rows. The teeth in adjacent rows are offset from each other. | 05-15-2014 |
20140243896 | SYSTEMS AND METHODS FOR FACET JOINT TREATMENT - A method of treating a facet joint of a patient. The facet joint includes a superior articular face and an inferior articular face. An implant is secured to an implant insertion tool by mating a first engagement feature on the implant with a second engagement feature on the implant insertion tool. A distal end of a guide cannula is positioned proximate the facet joint. The guide cannula has an internal passage extending therethrough. The implant slides through the guide cannula passage until the implant passes through a distal end of the guide cannula passage and is at least partially between the superior articular face and the inferior articular face. A force of at least 1 Newton is exerted on the implant insertion tool to separate the first engagement feature and the second engagement feature. | 08-28-2014 |
20150119988 | SYSTEM AND METHODS FOR FACET JOINT TREATMENT - A method of resurfacing a facet joint with a facet implant system. The facet joint includes a superior facet and an inferior facet that are adjacent to each other and movable with respect to each other. A first facet implant component is provided that has a first visualization marker. The first visualization marker includes a first marker section and a second marker section. The first marker section is oriented at an angle with respect to the second marker section. The first facet implant component between the superior facet and the inferior facet. A location and an orientation of the first facet implant component are determined using an imaging technique that locates the first visualization marker. | 04-30-2015 |
20150327872 | METHOD OF PERFORMING SACROILIAC FUSION - A method of performing an orthopedic procedure in a sacroiliac region. At least a portion of an undercutting system is inserted at least partially into an aperture in at least one of an ilium and a sacrum. The undercutting system includes an insertion apparatus, a probe assembly and a cutting assembly. The probe assembly is moved with respect to the insertion apparatus from a retracted position to an extended position so that at least a portion of the probe assembly is between the ilium and the sacrum. The probe assembly is manipulated between the ilium and the sacrum. The cutting assembly is moved with respect to the insertion apparatus from a refracted position to an extended position so that at least a portion of the probe assembly is between the ilium and the sacrum. The cutting assembly is manipulated between the ilium and the sacrum to cut tissue between the ilium and the sacrum. | 11-19-2015 |
Patent application number | Description | Published |
20080255994 | Content Preview - Techniques enable creation of a preview license for digital content. In some instances, the preview license indicates that it allows a content-consuming device to consume less than all of the content. This preview license may create a list specifying multiple portions of the digital content that the content-consuming device may consume. These techniques may also present to a device user an offer to purchase rights to consume all of the digital content after consumption of the preview-licensed portion(s). In other instances, a content server may embed the preview license into a content package that contains the digital content, allowing the server to distribute the package to multiple devices. In still other instances, the preview license may be bound to a domain rather than to individual devices. This allows member devices to share the digital content and the preview license, such that each member device may enjoy the preview experience. | 10-16-2008 |
20080256592 | Managing Digital Rights for Multiple Assets in an Envelope - Techniques enable building a collection of data that defines an asset, with the data possibly having differing data types. These techniques are then capable of assigning arbitrary policy to that asset, regardless of which data types are present within the asset. In addition, these techniques enable packaging of this first asset with one or more additional assets in a self-contained envelope. Each asset within the envelope may similarly include data of differing data types. Furthermore, each of these assets may be assigned a policy that may be different than the policy assigned to the first asset. This envelope, or a collection of envelopes, may then be provided to a content-consuming device to consume the assets in accordance with each asset's specified policy. | 10-16-2008 |
Patent application number | Description | Published |
20110237785 | SPATIALLY-DEFINED MACROCYCLIC COMPOUNDS USEFUL FOR DRUG DISCOVERY - Novel spatially-defined macrocyclic compounds containing specific conformational control elements are disclosed. Libraries of these macrocycles are then used to select one or more macrocycle species that exhibit a specific interaction with a particular biological target. In particular, compounds according to the invention are disclosed as agonists or antagonists of a mammalian motilin receptor and a mammalian ghrelin receptor. | 09-29-2011 |
20120270769 | METHODS OF USING MACROCYCLIC INHIBITORS OF SERINE PROTEASE ENZYMES - The present invention relates to novel macrocyclic compounds and salts thereof that bind to and/or are inhibitors of serine protease enzymes and methods of using the compounds. The present invention also relates to intermediates of these compounds, pharmaceutical compositions containing these compounds and methods of using the same. These compounds are useful as therapeutics for treatment and prevention of a range of disease indications including hyperproliferative disorders, in particular those characterized by tumor metastasis, inflammatory disorders, skin and tissue disorders, cardiovascular disorders, respiratory disorders and viral infections. | 10-25-2012 |
20120270807 | MACROCYCLIC INHIBITORS OF SERINE PROTEASE ENZYMES - The present invention relates to novel macrocyclic compounds and salts thereof that bind to and/or are inhibitors of serine protease enzymes. The present invention also relates to intermediates of these compounds, pharmaceutical compositions containing these compounds and methods of using the compounds. These compounds are useful as therapeutics for treatment and prevention of a range of disease indications including hyperproliferative disorders, in particular those characterized by tumor metastasis, inflammatory disorders, skin and tissue disorders, cardiovascular disorders, respiratory disorders and viral infections. | 10-25-2012 |
Patent application number | Description | Published |
20090137817 | SPATIALLY-DEFINED MACROCYCLIC COMPOUNDS USEFUL FOR DRUG DISCOVERY - Novel spatially-defined macrocyclic compounds containing specific conformational control elements are disclosed. Libraries of these macrocycles are then used to select one or more macrocycle species that exhibit a specific interaction with a particular biological target. In particular, compounds according to the invention are disclosed as agonists or antagonists of a mammalian motilin receptor and a mammalian ghrelin receptor. | 05-28-2009 |
20090198050 | Macrocyclic Modulators of the Ghrelin Receptor - The present invention provides novel conformationally-defined macrocyclic compounds that have been demonstrated to be selective modulators of the ghrelin receptor (growth hormone secretagogue receptor, GHS-R1a and subtypes, isoforms and variants thereof). Methods of synthesizing the novel compounds are also described herein. These compounds are useful as agonists of the ghrelin receptor and as medicaments for treatment and prevention of a range of medical conditions including, but not limited to, metabolic and/or endocrine disorders, gastrointestinal disorders, cardiovascular disorders, obesity and obesity-associated disorders, central nervous system disorders, genetic disorders, hyperproliferative disorders and inflammatory disorders. | 08-06-2009 |
20090240027 | INTERMEDIATES FOR MACROCYCLIC COMPOUNDS - The present invention is directed to novel macrocyclic compounds of formula (I) and their pharmaceutically acceptable salts, hydrates or solvates: | 09-24-2009 |
20090312540 | SPATIALLY-DEFINED MACROCYCLES INCORPORATING PEPTIDE BOND SURROGATES - Novel spatially-defined macrocyclic compounds incorporating peptide bond surrogates are disclosed. Libraries of these macrocycles are then used to select one or more macrocycle species that exhibit a specific interaction with a particular biological target, in particular, compounds according to the invention are disclosed as agonists or antagonists of a mammalian motilin receptor and a mammalian ghrelin receptor. | 12-17-2009 |
20110105389 | Macrocyclic Ghrelin Receptor Antagonists and Inverse Agonists and Methods of Using the Same - The present invention provides novel conformationally-defined macrocyclic compounds that have been demonstrated to be selective modulators of the ghrelin receptor (GRLN, growth hormone secretagogue receptor, GHS-R1a and subtypes, isoforms and/or variants thereof). Methods of synthesizing the novel compounds are also described herein. These compounds are useful as antagonists or inverse agonists of the ghrelin receptor and as medicaments for treatment and prevention of a range of medical conditions including, but not limited to, metabolic and/or endocrine disorders, obesity and obesity-associated disorders, appetite or eating disorders, addictive disorders, cardiovascular disorders, gastrointestinal disorders, genetic disorders, hyperproliferative disorders, central nervous system disorders and inflammatory disorders. | 05-05-2011 |
20110245459 | Processes for Intermediates for Macrocyclic Compounds - The present invention is directed to novel macrocyclic compounds of formula (I) and their pharmaceutically acceptable salts, hydrates or solvates: | 10-06-2011 |